-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2024.
- Akero Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1K, a 90.9% decline year-over-year.
- Akero Therapeutics, Inc. annual Depreciation for 2023 was $29K, a 32.6% decline from 2022.
- Akero Therapeutics, Inc. annual Depreciation for 2022 was $43K, a 4.88% increase from 2021.
- Akero Therapeutics, Inc. annual Depreciation for 2021 was $41K, a 141% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)